Clinical trial
The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer
NCT06540027 is registered in ClinicalTrials.gov with Başakşehir Çam & Sakura City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer
- Lead sponsor
- Başakşehir Çam & Sakura City Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2024
- Completion date
- March 1, 2025
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal adenocarcinoma, colorectal cancer, immune system disorder, rectal cancer, rectal cancer stage